1. Lee HY, Lim S, Park S. Role of inflammation in arterial calcification. Korean Circ J. 2021; 51:114–125. PMID:
33525066.
Article
2. Galougahi KK, Shlofmitz E, Jeremias A, et al. Therapeutic approach to calcified coronary lesions: disruptive technologies. Curr Cardiol Rep. 2021; 23:33. PMID:
33666772.
Article
3. Arunima Kaul A, Dhalla PS, Bapatla A, et al. Current treatment modalities for calcified coronary artery disease: a review article comparing novel intravascular lithotripsy and traditional rotational atherectomy. Cureus. 2020; 12:e10922. PMID:
33194488.
4. Hill JM, Kereiakes DJ, Shlofmitz RA, et al. Intravascular lithotripsy for treatment of severely calcified coronary artery disease. J Am Coll Cardiol. 2020; 76:2635–2646. PMID:
33069849.
Article
5. Kereiakes DJ, Di Mario C, Riley RF, et al. Intravascular lithotripsy for treatment of calcified coronary lesions: patient-level pooled analysis of the disrupt CAD studies. JACC Cardiovasc Interv. 2021; 14:1337–1348. PMID:
33939604.
6. Aksoy A, Salazar C, Becher MU, et al. Intravascular lithotripsy in calcified coronary lesions: a prospective, observational, multicenter registry. Circ Cardiovasc Interv. 2019; 12:e008154. PMID:
31707803.
7. Umapathy S, Keh YS, Wong N, et al. Real-world experience of coronary intravascular lithotripsy in an asian population: a retrospective, observational, single-center, all-comers registry. J Invasive Cardiol. 2021; 33:E417–E424. PMID:
33893792.
8. Wong JJ, Umapathy S, Keh YS, et al. Coronary intravascular lithotripsy versus rotational atherectomy in an Asian population: clinical outcomes in real-world patients. Korean Circ J. 2022; 52:288–300. PMID:
35043608.
Article